Drug
Bromocriptine Mesylate
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Neuroleptic Malignant Syndrome | 24 | 65.6 | 68.1 | signal |
| 2 | Muscle Rigidity | 16 | 43.5 | 44.6 | signal |
| 3 | Drug Exposure During Pregnancy | 25 | 23.5 | 24.4 | signal |
| 4 | Mitral Valve Incompetence | 7 | 20.1 | 20.3 | signal |
| 5 | Blood Creatine Phosphokinase Increased | 18 | 20.0 | 20.5 | signal |
| 6 | Caesarean Section | 7 | 19.3 | 19.5 | signal |
| 7 | Serotonin Syndrome | 11 | 18.7 | 19.0 | signal |
| 8 | Status Epilepticus | 6 | 17.2 | 17.4 | signal |
| 9 | Hallucination, Visual | 11 | 17.0 | 17.3 | signal |
| 10 | Delusion | 8 | 16.8 | 17.0 | signal |
| 11 | Blood Lactate Dehydrogenase Increased | 8 | 16.3 | 16.5 | signal |
| 12 | Parkinsonism | 4 | 13.3 | 13.4 | signal |
| 13 | Premature Baby | 12 | 12.9 | 13.1 | signal |
| 14 | Psychotic Disorder | 11 | 12.1 | 12.3 | signal |
| 15 | Injection Site Nodule | 4 | 11.8 | 11.9 | signal |
| 16 | Psychomotor Hyperactivity | 6 | 11.7 | 11.8 | signal |
| 17 | Abnormal Behaviour | 14 | 11.4 | 11.6 | signal |
| 18 | Myoclonus | 4 | 10.9 | 11.0 | signal |
| 19 | Blood Glucose Decreased | 14 | 9.4 | 9.6 | signal |
| 20 | Apathy | 4 | 8.9 | 9.0 | signal |
| 21 | Drug Resistance | 7 | 8.8 | 8.9 | signal |
| 22 | Hallucination, Auditory | 4 | 8.2 | 8.2 | signal |
| 23 | Premature Delivery | 4 | 8.1 | 8.2 | signal |
| 24 | Anorexia | 3 | 7.5 | 7.5 | signal |
| 25 | Drug Toxicity | 3 | 7.1 | 7.1 | signal |
| 26 | Glycosylated Haemoglobin Increased | 5 | 6.4 | 6.5 | signal |
| 27 | Foetal Exposure During Pregnancy | 11 | 4.4 | 4.5 | signal |
| 28 | Bladder Cancer | 6 | 3.3 | 3.3 | signal |